2m 2m 2m 2m 2m 2m 2m
Aclaris Therap (ACRS)
NASDAQ
$5.50-$0.005 (-0.09%)
Price as of Jul 14, 2026 11:29 AM EDT- $768.2MMarket Cap
- 248.10%1-Year Change
- BiotechnologyIndustry
Aclaris Therap (ACRS)
$5.50-$0.005 (-0.09%)
ACRS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.50 | ||
Change | -$0.08 (-1.43%) | ||
Open | $5.53 | ||
High | $5.58 | ||
Low | $5.35 | ||
Previous Close | $5.58 | ||
Volume | 1,087,870 | ||
30-Day Average Volume | 2,175,250 | ||
1-Week Change | 0.18% | ||
1-Month Change | 27.31% | ||
1-Year Change | 248.10% | ||
3-Year Change | -49.36% | ||
5-Year Change | -67.36% | ||
Fundamentals | |||
Shares Outstanding | 139.7M | ||
Total Assets | $198.7M | ||
Market Cap | $768.2M | ||
Enterprise Value | $739.5M | ||
Period: QTR TTM FY | |||
Revenue | $537,000.00 | ||
Net Income | -$19.8M | ||
Free Cash Flow | -$18.2M | ||
EBIT | -$19.8M | ||
EBITDA | -$19.7M | ||
Net Working Capital | $82.9M | ||
EPS | -$0.15 | ||
Enterprise Value/EBITDA | -37 | ||
Enterprise Value/Revenue | 1,377 | ||
P/B | 5 | ||
P/E | -37 | ||
PEG | -5 | ||
Price/Free Cash Flow | -42 | ||
Price/Operating Cash Flow | -42 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue